ACM Research, Inc. ACMR R2KAI
Company Overview
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells capital equipment in Mainland China and internationally. It also develops, manufactures, and sells a range of packaging tools to wafer assembly and packaging customers. The company provides wet cleaning equipment for front end production processes; electrochemical plating, furnace, PECVD, and track platforms; Space Alternated Phase Shift, technology for flat and wafer surfaces; timely energized bubble oscillation, technology for patterned wafer surfaces at advanced process nodes; and Tahoe technology; and semi-critical cleaning tools. It also offers advanced packaging equipment, such as coaters, developers, photoresist strippers, scrubbers, wet etchers and copper-plating equipment; and advanced packaging products include: Ultra ECP ap, which delivers a uniform metal layer to finished wafers prior to packaging; Ultra C Developer, which applies liquid developer to selected parts of photoresist to resolve an image; Ultra C PR Megasonic-Assisted Stripper, which removes photoresist; Ultra C Scrubber, which scrubs and cleans wafers; Ultra C Thin Wafer Scrubber, which addresses a sub-market of cleaning very thin wafers for certain Asian assembly factories; and Ultra C Wet Etcher, which etches silicon wafers and copper and titanium interconnects. In addition, the company provides ECP technology for advanced metal plating; Ultra fn Furnace, a dry processing tool; Ultra Pmax PECVD tools, a proprietary designed chamber, gas distribution unit, and chuck; and Ultra Track, a 300mm process tool that delivers uniform air downflow, fast robot handling and configurable software to address specific customer requirements. It markets and sells its products under the SAPS, TEBO, ULTRA C, ULTRA Fn, Ultra ECP, Ultra ECP map, and Ultra ECP ap trademarks through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.
Why Investors Should Care
Net profit has compounded at 33.8% per year over the last five years.
Revenue has grown at a 32.3% CAGR over the past five years.
Operating margin of 15.6% supports profitability.
Carries low leverage with a debt-to-equity ratio of 0.16.
Recent Developments
- Dec 2025 Revenue of $901.31M (+15.2% YoY); net profit $94.08M.
- Trailing 12 Months Year-on-year growth — revenue +34.2%, earnings -18.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 32.3%, profit CAGR 33.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 32.34% |
| 1 Year: | 34.20% |
Compounded Profit Growth
| 5 Years: | 33.81% |
| 1 Year: | -18.70% |
Stock Price Performance
| 1 Year: | +241.84% |
| 6 Months: | +85.82% |
| 3 Months: | +99.30% |
| 1 Month: | +7.85% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
ACM Research makes wafer-cleaning and other front-end equipment used to fabricate the advanced chips that power AI.
Wet-cleaning, electrochemical plating, furnace and advanced-packaging tools for semiconductor manufacturers.
- Cleaning tools for advanced nodes ACM's wet-cleaning equipment is critical to fabricating the logic and memory chips serving AI.
- Advanced-packaging tools Packaging equipment addresses the heterogeneous integration used in AI accelerators.
- China & global expansion Strong China demand plus international expansion broaden its served market.
- Fast-growing equipment supplier (~34% growth) levered to the AI-chip build-out.
- Profitable (net ~10%) and gaining share in cleaning and plating.
- Heavy China exposure carries geopolitical and concentration risk.
- Semiconductor-capex cyclicality is a key risk.
Curated from public filings and analyst commentary; figures are illustrative.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 32.3% over 5 years.
- Profit CAGR of 33.8% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 75.5.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ACMR ACM Research, Inc. R2KAI | 98.90 | 75.50 | $6.34B | 0.00% | 6.68% | 7.60% | 32.34% | 33.81% |
| 2 | NVDA NVIDIA Corporation NDXSPXAI | 211.80 | 32.43 | $5.13T | 0.49% | 74.66% | 114.29% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPX | 314.86 | 38.07 | $4.62T | 0.37% | 68.72% | 141.47% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXAI | 384.93 | 22.91 | $2.86T | 0.93% | 26.90% | 34.01% | 9.48% | 10.85% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AI | 420.39 | 36.18 | $2.18T | 0.90% | 30.20% | 36.21% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXAI | 389.11 | 64.85 | $1.85T | 0.68% | 16.70% | 37.28% | 24.38% | 26.24% |
| 7 | MU Micron Technology, Inc. NDXSPXAI | 983.12 | 46.37 | $1.11T | 0.06% | 13.69% | 39.82% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXAI | 548.13 | 181.50 | $893.78B | 0.00% | 6.33% | 8.06% | 13.64% | 48.64% |
| 9 | ASML ASML Holding N.V. NDXAI | 1,775.64 | 59.55 | $684.36B | 0.47% | 42.97% | 52.24% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | 23.18M | 20.48M | 29.01M | 33.43M | 24.35M | 39.05M | 47.66M | 43.73M | 53.86M | 67.01M | 42.19M | 104.39M | 133.71M | 74.26M | 144.58M | 168.57M | 152.19M | 202.48M | 203.98M | 172.35M | 215.37M | 269.16M | 244.43M | 231.26M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 89.80M | 110.91M | 156.01M | 144.52M | 124.03M |
| Gross Profit | 2.92M | 2.40M | 3.45M | 2.20M | 5.12M | 8.72M | 10.29M | 8.83M | 13.13M | 16.25M | 10.23M | 19.36M | 20.34M | 18.05M | 21.68M | 29.68M | 19.69M | 44.16M | 65.97M | 39.99M | 68.64M | 88.51M | 79.12M | 96.78M | 104.83M | 82.55M | 104.46M | 113.15M | 99.91M | 107.24M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 56.77M | 72.77M | 84.23M | 76.87M | 71.06M |
| Operating Income | 788.00K | -1.55M | -202.00K | -1.31M | -1.90M | 2.33M | 3.40M | 2.25M | 4.66M | 7.03M | 1.22M | 7.34M | 7.51M | 3.45M | 4.33M | 11.79M | -9.31M | 20.04M | 31.64M | 8.86M | 30.43M | 33.17M | 25.23M | 37.59M | 44.18M | 25.78M | 31.69M | 28.92M | 23.04M | 36.18M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.74M | 43.26M | 55.04M | 28.43M | 37.41M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.56M | 1.76M | 1.85M | 1.79M | 1.93M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 27.17M | 38.16M | 49.09M | 20.78M | 30.01M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.15M | 1.89M | 2.69M | 6.57M | 3.77M |
| Net Income | 362.00K | -2.09M | -658.00K | -955.00K | -2.78M | 3.21M | 3.85M | 1.86M | 4.31M | 8.78M | 1.71M | -81.00K | 8.63M | 5.47M | 6.57M | 10.15M | -5.79M | 12.24M | 21.00M | 7.14M | 26.82M | 25.68M | 17.43M | 24.21M | 30.90M | 20.38M | 29.76M | 35.89M | 8.05M | 17.31M |
| Diluted EPS | 0.05 | -0.43 | -0.13 | -0.17 | -0.18 | 0.18 | 0.21 | 0.10 | 0.23 | 0.45 | 0.08 | 0.00 | 0.40 | 0.08 | 0.10 | 0.15 | -0.10 | 0.18 | 0.32 | 0.11 | 0.41 | 0.39 | 0.26 | 0.35 | 0.45 | 0.30 | 0.44 | 0.52 | 0.11 | 0.24 |
| R&D Expense | 813.00K | 928.00K | 939.00K | 1.21M | 1.54M | 2.42M | 2.26M | 2.77M | 3.34M | 3.49M | 3.68M | 5.22M | 4.34M | 5.50M | 7.93M | 7.86M | 17.35M | 11.37M | 15.68M | 14.03M | 20.06M | 26.15M | 23.92M | 25.97M | 27.84M | 27.50M | 33.82M | 39.65M | - | 36.55M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.37M | 36.51M | 74.64M | 107.52M | 156.62M | 259.75M | 388.83M | 557.72M | 782.12M | 901.31M |
| Cost of Revenue | - | - | - | - | - | - | 205.22M | 281.51M | 390.56M | 501.24M |
| Gross Profit | 13.33M | 17.23M | 34.45M | 50.65M | 69.60M | 114.86M | 183.62M | 276.21M | 391.55M | 400.07M |
| Operating Expenses | - | - | - | - | - | - | 124.58M | 180.38M | 240.56M | 290.64M |
| Operating Income | 3.49M | 700.00K | 6.47M | 17.79M | 21.49M | 38.70M | 59.03M | 95.84M | 151.00M | 109.43M |
| EBITDA | - | - | - | - | - | - | 74.38M | 126.99M | 180.42M | 158.47M |
| Interest Expense | - | - | - | - | - | - | 1.66M | 2.68M | 4.15M | 6.96M |
| Pretax Income | - | - | - | - | - | - | 67.36M | 116.22M | 166.30M | 135.19M |
| Tax Provision | - | - | - | - | - | - | 16.80M | 19.36M | 35.03M | 13.30M |
| Net Income | 1.03M | -318.00K | 6.57M | 18.89M | 18.78M | 37.76M | 39.26M | 77.35M | 103.63M | 94.08M |
| Diluted EPS | 0.18 | -0.05 | 0.37 | 0.99 | 0.30 | 0.58 | 0.59 | 1.16 | 1.53 | 1.37 |
| R&D Expense | 3.26M | 5.14M | 10.38M | 12.90M | 19.12M | 34.21M | 62.23M | 92.71M | 105.47M | 144.99M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 44.47M | 67.89M | 103.05M | 217.70M | 341.26M | - | 1.24B | 1.49B | 1.86B | 2.87B |
| Current Assets | - | - | - | - | - | - | - | 963.81M | 1.18B | 1.48B | 2.44B |
| Cash & Equivalents | 4.40M | 10.12M | 17.68M | 27.12M | 58.26M | 71.77M | - | 247.95M | 182.09M | 407.44M | 757.37M |
| Inventory | - | - | - | - | - | - | - | 393.17M | 545.39M | 597.98M | 702.63M |
| Receivables | - | - | - | - | - | - | - | 182.94M | 283.19M | 387.05M | 504.25M |
| Total Liabilities | - | 23.95M | 28.03M | 50.72M | 60.22M | 133.09M | - | 423.33M | 564.75M | 759.82M | 941.68M |
| Current Liabilities | - | 17.07M | 21.82M | 46.14M | 53.50M | 102.91M | - | 396.21M | 500.66M | 641.23M | 745.71M |
| Long Term Debt | - | - | - | - | 0 | 17.98M | - | 18.69M | 53.95M | 105.53M | 178.93M |
| Total Debt | - | - | - | - | - | - | - | 79.50M | 99.10M | 188.78M | 297.91M |
| Total Equity | -4.48M | -2.43M | 39.86M | 52.32M | 97.32M | 141.15M | - | 674.86M | 767.39M | 904.62M | 1.46B |
| Shares Outstanding | - | - | - | - | - | - | - | 59.68M | 61.06M | 62.96M | 65.61M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | 6.91M | 9.40M | -13.55M | - | -62.19M | -75.32M | 152.45M | -10.32M |
| Investing Cash Flow | - | - | -2.07M | -5.53M | -69.95M | - | -265.67M | -6.75M | -11.96M | -390.33M |
| Financing Cash Flow | - | - | 5.12M | 87.44M | 32.83M | - | 45.87M | 18.53M | 92.48M | 742.49M |
| Capital Expenditure | -795.00K | -651.00K | -1.83M | -971.00K | -5.21M | - | -92.52M | -64.34M | -85.95M | -57.66M |
| Free Cash Flow | - | - | 5.08M | 8.43M | -18.76M | - | -154.71M | -139.66M | 66.50M | -67.98M |
| Net Change in Cash | - | - | - | - | - | - | -281.99M | -63.54M | 232.97M | 341.83M |
| Share Buybacks | - | - | 0 | 2.83M | 0 | 0 | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 48.7% | 47.2% | 46.2% | 47.1% | 44.4% | 44.2% | 47.2% | 49.5% | 50.1% | 44.4% |
| Operating Margin % | 12.8% | 1.9% | 8.7% | 16.5% | 13.7% | 14.9% | 15.2% | 17.2% | 19.3% | 12.1% |
| Net Margin % | 3.8% | -0.9% | 8.8% | 17.6% | 12.0% | 14.5% | 10.1% | 13.9% | 13.2% | 10.4% |
| ROE % | -42.4% | -0.8% | 12.6% | 19.4% | 13.3% | - | 5.8% | 10.1% | 11.5% | 6.4% |
| ROCE % | 12.7% | 1.5% | 11.4% | 10.8% | 9.0% | - | 7.0% | 9.7% | 12.4% | 5.1% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ACMR
ACM Research, Inc. (ACMR) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching ACM Research (ACMR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why ACM Research, Inc. (ACMR) Dipped More Than Broader Market Today
In the latest trading session, ACM Research, Inc. (ACMR) closed at $94.66, marking a -3.92% move from the previous day.
Is ACM Research (ACMR) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for ACM Research (ACMR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth…
ACM Research, Inc. (ACMR) Suffers a Larger Drop Than the General Market: Key Insights
ACM Research, Inc. (ACMR) concluded the recent trading session at $117.16, signifying a -7.67% move from its prior day's close.
ACM Research, Inc. (ACMR) is Attracting Investor Attention: Here is What You Should Know
ACM Research (ACMR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Roth Capital Raises PT on ACM Research (ACMR)
ACM Research, Inc. (NASDAQ:ACMR) is one of the Best Growth Stocks to Buy and Hold for the Next Decade. Recently, on June 18, Roth Capital raised the firm’s price target on ACM Research, Inc. (NASDAQ:ACMR) from $100 to $125 and maintained a…
ACMR — Frequently Asked Questions
What is the current share price of ACM Research, Inc. (ACMR)?
As of 2026-07-14 21:23 PDT, ACM Research, Inc. (ACMR) trades at $98.90 on NasdaqGM. Its 52-week range is $23.92 to $126.89.
What is the market capitalisation of ACMR?
ACM Research, Inc. (ACMR) has a market capitalisation of $6.34B on NasdaqGM.
What is the P/E ratio of ACMR?
ACMR trades at a trailing price-to-earnings (P/E) ratio of 75.50. The industry average P/E is 36.02. Its price-to-book (P/B) ratio is 3.93.
What is the return on equity (ROE) of ACMR?
ACMR has a return on equity (ROE) of 7.60%. Its return on capital employed (ROCE) is 6.68%.
Is ACMR a good stock to buy?
This page provides a data-driven analysis of ACM Research, Inc. (ACMR), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.